{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:25:39Z","timestamp":1793953539586,"version":"4.8.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.cpcardiol.2022.101412","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T02:05:34Z","timestamp":1664157934000},"page":"101412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness of Sacubitril\/Valsartan in Heart Failure with Reduced Ejection Fraction Using Real-World Data: An Updated Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2631-0184","authenticated-orcid":false,"given":"Alaa","family":"Rahhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Kasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassant","family":"Orabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Hamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safae","family":"Abuyousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaya","family":"Alyafei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Emad","family":"Shoukry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2022.101412_bib0001","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0002","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart failure with reduced ejection fraction: a review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0003","first-page":"678","article-title":"Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Tsao","year":"2018","journal-title":"JACC: heart failure"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0004","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0005","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/heartjnl-2014-306775","article-title":"The neprilysin pathway in heart failure: a review and guide on the use of sacubitril\/valsartan","volume":"102","author":"Jhund","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0006","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0007","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ejhf.1498","article-title":"Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study","volume":"21","author":"Wachter","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0008","first-page":"531","article-title":"CCS\/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction","volume":"37","author":"McDonald","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0009","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"Maddox","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0010","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0011","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00059-017-4671-1","article-title":"Sacubitril\/valsartan for heart failure with reduced left ventricular ejection fraction: a retrospective cohort study","volume":"44","author":"De Vecchis","year":"2019","journal-title":"Herz"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0012","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1038\/s41598-020-63801-2","article-title":"Clinical and echocardiographic benefit of Sacubitril\/Valsartan in a real-world population with HF with reduced ejection fraction","volume":"10","author":"Polito","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0013","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jchf.2019.08.003","article-title":"Comparative effectiveness of sacubitril-valsartan versus ACE\/ARB therapy in heart failure with reduced ejection fraction","volume":"8","author":"Tan","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021459","article-title":"Clinical effectiveness of sacubitril\/valsartan among patients hospitalized for heart failure with reduced ejection fraction","volume":"10","author":"Greene","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101149","article-title":"Clinical outcomes of Sacubitril\/Valsartan in patients with acute heart failure: a multi-institution study","volume":"41","author":"Chen","year":"2021","journal-title":"EClinicalMedicine."},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0016","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12872-021-02145-9","article-title":"Real-world experience of angiotensin receptor\/neprilysin inhibitor (ARNI) usage in Thailand: a single-center, retrospective analysis","volume":"21","author":"Rattanavipanon","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0017","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00015385.2018.1473825","article-title":"Impact of sacubitril\/valsartan on heart failure admissions: insights from real-world patient prescriptions","volume":"74","author":"Martens","year":"2019","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0018","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s12325-018-0710-4","article-title":"An early view of real-world patient response to sacubitril\/valsartan: a retrospective study of patients with heart failure with reduced ejection fraction","volume":"35","author":"Antol","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0019","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/FJC.0000000000000641","article-title":"Sacubitril\/valsartan in daily clinical practice: data from a prospective registry","volume":"73","author":"Vicent","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cpcardiol.2022.101412_bib0020","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1002\/ehf2.13547","article-title":"Sacubitril\/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis","volume":"8","author":"Giovinazzo","year":"2021","journal-title":"ESC Heart Fail"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622003097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622003097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:00:22Z","timestamp":1758938422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280622003097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0146280622003097"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101412","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Sacubitril\/Valsartan in Heart Failure with Reduced Ejection Fraction Using Real-World Data: An Updated Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101412"}}